CAT-1 (SLC7A1) has been reported to be overexpressed in colorectal cancer [80], breast cancer cell lines [81], and chronic lymphocytic leukemia (CLL) [82]. Here, SLC7A1 is linked to B-cell chronic lymphocytic leukemia.